Ikarian Capital, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
A detailed history of Ikarian Capital, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 485,021 shares of TARS stock, worth $21 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
485,021
Previous 607,689
20.19%
Holding current value
$21 Million
Previous $33.6 Million
25.95%
% of portfolio
3.49%
Previous 5.55%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$144 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$141 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$113 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$108 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$106 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.15B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...